Status:
COMPLETED
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
Lead Sponsor:
Viome
Conditions:
Depression, Anxiety
IBS - Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrom...
Detailed Description
Participants receive Viome Precision Nutrition Program (VPNP) after completing the health assessment and questionnaire. VPNP consists of diet, supplement and recommendations based on results from thei...
Eligibility Criteria
Inclusion
- PHQ-9 score 5 or above
- GAD-7 score 5 or above
- IBS ROME-IV score 125 or above
- Females and males aged 18 years or older
- Signed and dated informed consent prior to any trial-specific procedures are performed
- Able to speak and read English
- Willing and able to follow the trial instructions
- Viome existing costumer
Exclusion
- Unable/unwilling to complete the provided questionnaires
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2022
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04905524
Start Date
September 1 2020
End Date
March 23 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Viome Research Institute
Bothell, Washington, United States, 98011